Skip to content
Search

Latest Stories

Half a million more at risk of type 2 diabetes in England in one year

Half a million more at risk of type 2 diabetes in England in one year

There was an almost 25 per cent increase in the number of individuals under the age of 40 at risk of type 2 diabetes

The number of people in England identified as at risk for type 2 diabetes mellitus (T2DM) has increased by over half a million within a year, according to NHS figures.


Data released by the National Diabetes Audit on June 12 showed that 3.6 million people registered with a GP were found to have non-diabetic hyperglycaemia (also known as pre-diabetes) in 2023, compared with 3.1 million people in 2022 — a notable 18 per cent increase or nearly 550,000 people.

Among those under 40 years old, the figures showed an increase of almost 25 per cent from 173,166 in 2022 to 216,440 in 2023.

People with non-diabetic hyperglycaemia have higher-than-normal blood sugar levels, and they are at greater risk for developing type 2 diabetes and cardiovascular diseases. Typically, this condition is detected through routine blood tests at GP surgeries.

Amanda Pritchard, NHS chief executive, expressed deep concern over the figures, emphasising that type 2 diabetes is not only linked to kidney failure, amputation, heart attack, stroke, and many of the common types of cancer, but it also adds pressure to NHS services.

She assured that the NHS will continue to develop services that support people at risk of developing type 2 diabetes to lead healthier lives.

The NHS has introduced a range of innovative services to prevent people from developing type 2 diabetes and to reduce obesity rates, including the world-leading Healthier You NHS Diabetes Prevention Programme.

More than 1.6 million people have been offered support through the nine-month programme, which provides personalised support with practical tools and advice on healthy eating and lifestyle, increasing physical activity and weight management.

Dr. Clare Hambling, National Clinical Director of Diabetes and Obesity at NHS England, highlighted that the prevalence of type 2 diabetes among individuals under 40 is increasing worldwide, including in England.

According to the NHS, around nine out of 10 people in England living with diabetes have type 2.

The NHS England-funded Type 2 Diabetes and the Young (T2DAY) initiative ensures that people living with early-onset type 2 diabetes receive all recommended diabetes health checks, personalised support tailored to their needs, and evidence-based management to stay well and avoid complications.

It includes additional clinical reviews for those aged 18 to 39 years old living with type 2 diabetes.

The ambitious programme, now entering its second year, is believed to be the world-first targeted support for these high-risk people living with diabetes.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less